Investors & Media

SEC Filings

Document Details

Form
Filing Date
June 10, 2021
Document Date
June 8, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
PERLMUTTER ROGER M

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com